Medizone International, Inc. (OTCBB: MZEI) From a commercial viewpoint, the higher the “kill rate” in the shortest turn around time, the more favorably physicians and hospital administrators will view the system. Accordingly, Medizone now believes that the performance profile of its AsepticSure™ Sterilization System will exceed all the prerequisite requirements of affordability, practicability and unmatched efficacy, which will catapult it into the world market.

What we are witnessing here is not only AsepticSure  moving beyond expectations in its hospital setting but broading the product scope and potential sales into bioterrorism applications.

AsepticSure™ BioTerrorism Applications

A field hardened version of AsepticSure™ is anticipated to be used in bioterrorism settings internationally as it will be easily deployable in response to virtually any terrorist assault, extremely effective against a broad range of lethal pathogens, easy to manage and maintain and has the potential to save lives. The potential of being able to eliminate 99.999992% (7.2 log kill) of an internationally accepted surrogate for Anthrax in 90 minutes will have national security implications.

This is precisely the time in the life of a biotech that you want to be on boaord.

January 20. 2010, Update

Unprecedented Kill Rates Foundation for Second Patent Application and Full Scale Hospital Mockup Underway

Medizone International announced unprecedented success in being able to predictably achieve 6 log (99.9999%) kill rates for the causative agents of Hospital Acquired Infections (HAIs) represented with AsepticSure™.

All samples tested during the third round of trials were either completely destroyed, that is no growth compared to the control samples, or so significantly reduced that the effect met the 6 log definition for sterilization.

These are the biggest culprits in hospital deaths for hospital acquired infections.  MZEI is hitting the bullseye here. NO DOUBT ABOUT IT.

This is HUGE.

The actual results of this series of tests indicate reductions in pathogens, commonly associated with HAIs, can reliably be achieved by AsepticSure™ as follows:

• >6.5 log for C difficile
• >7 log for MRSA
• 7 log for E-coli
• 6.6 log for VRE
• 7 log for Pseudomonas aeruginous
• > 7 log for Bacillus subtilis

The sterilization of contaminated hospital spaces with a fully portable unit is now within reach without enormous expense, which will translate into greatly reduced suffering, thousands of lives saved and a dramatic cost benefit for the health care system globally.

Full Scale Hospital Mock Up Underway

Medizone’s research has now progressed to the full-scale mock up. By introducing the same combinations and protocols to room scale testing that produced >6 log with all HAI pathogens in the laboratory, our research team is confident the results produced should coincide with what has already been achieved in the most recent round of laboratory trials. Initial results from these scale-up trials can be expected in the near future.

DO NOT WAIT ON THIS.  ONCE THE HOSPITAL MOCK UP RESULTS ARE ANNOUNCED THIS TRAIN MAY HAVE LEFT THE STATION.

YOU MAY NEVER FIND A BETTER TIME THAN NOW TO ABSOLUTELY GET ON BOARD.

Contact information:
Medizone International, Inc. (OTCBB: MZEI)
(See Medizone International Video)
http://www.medizoneint.com

Telephone: 415-868-0300
Fax: 415-868-2344
Address:
Post Office Box 742
Stinson Beach, CA 94970

Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 450,000 144 restricted common shars by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

On Monday, the company put out news announcing its participation as an exhibitor at the 2010 Barcelona GSMA Mobile World Congress February 15-18. The GSMA represents the interests of the worldwide mobile communications industry uniting the world’s mobile operators, handset makers, software companies, equipment providers, Internet companies and media organizations. Its annual convention is the largest mobile event of the year drawing approximately 50,000 attendees. This is Voiceserve, Inc’s first participation in the convention and is one of the only companies exhibiting a mobile VoIP dialer out of the 1,300 companies displaying their cutting-edge products and technology at the annual GSMA Mobile Congress. Voiceserve’s booth is located in the UK pavilion at Stand 1F61.

Shares for Voiceserve Inc. (OTCBB: VSRV) were down during the late afternoon of trading on Monday and closed down two cents at closing.
 

To view our StockGuru Spotlight on Voiceserve Inc. (OTCBB: VSRV), please visit:

http://www.stockguru.com 

What is the StockGuru Spotlight? 

The StockGuru Spotlight features stocks that we expect some action in. Generally speaking we expect a strong showing in the market based on the market, our knowledge of the stock and the buzz in the markets. Many times these will be stocks that have big news out recently, there is fresh interest in getting the word out on these stocks or we hear a buzz in our day to day contacts on these stocks. If we think it is going to move or see action, we put it in the StockGuru Spotlight.  If we are compensated for a stock in the Spotlight, it will be clearly disclosed within this Spotlight Announcement. 

If you think a company should be featued in the StockGuru Spotlight, please let us know. If you are a key person for a publicly traded company, we can consider your company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact our Publisher John Pentony at the john@stockguru.com.  You may also telephone John Pentony at (469) 252-3031. 

Stockguru.com (”SG”) provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.Stockguru.com or mentioned herein. 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. Pentony Enterprises LLC is occassionally compensated for coverage.  When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present, plus we also disclose any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. 
 

John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: john@stockguru.com

On Monday, the company put out news announcing that The Company has been issued a coveted “Designation” for its Quantum Sniffer™ technology under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act) from the U.S. Department of Homeland Security. The designation applies to the company’s QS-H100 and QS-H150 Portable Explosives Detectors.  The purpose of the SAFETY Act is to ensure that the threat of liability does not deter manufacturers of anti-terrorism technologies from developing and commercializing new products that could significantly reduce the risks or effects of terrorist events.

Shares for Implant Sciences Corp. (OTCBB: IMSC) were up during the late morning of trading on Monday and closed up thirteen cents at closing.
 

To view our StockGuru Spotlight on Implant Sciences Corp. (OTCBB: IMSC), please visit:

http://www.stockguru.com 

What is the StockGuru Spotlight? 

The StockGuru Spotlight features stocks that we expect some action in. Generally speaking we expect a strong showing in the market based on the market, our knowledge of the stock and the buzz in the markets. Many times these will be stocks that have big news out recently, there is fresh interest in getting the word out on these stocks or we hear a buzz in our day to day contacts on these stocks. If we think it is going to move or see action, we put it in the StockGuru Spotlight.  If we are compensated for a stock in the Spotlight, it will be clearly disclosed within this Spotlight Announcement. 

If you think a company should be featued in the StockGuru Spotlight, please let us know. If you are a key person for a publicly traded company, we can consider your company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact our Publisher John Pentony at the john@stockguru.com.  You may also telephone John Pentony at (469) 252-3031. 

Stockguru.com (”SG”) provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.Stockguru.com or mentioned herein. 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. Pentony Enterprises LLC is occassionally compensated for coverage.  When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present, plus we also disclose any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. 
 

John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: john@stockguru.com

On Monday, the company put out news announcing that it has begun distribution in Kansas through a distribution agreement with House of Schwan based in Wichita, Kansas.  House of Schwan was founded by Barney Schwan in 1960 and today remains a leading family owned and operated distributor in the state of Kansas. House of Schwan services over 800 customers with brands including Budweiser, Corona, and now New Leaf.  “New Leaf is a great fit for us,” stated Brian Schwan, Key Account Manager and Non-Alcoholic Brand Manager for House of Schwan. “We have been searching for a great tasting, thirst quenching, all natural tea brand such as New Leaf to provide our customers and today we are excited to meet that demand.” 

Shares for New Leaf Brands Inc. (OTCBB: NLEF) were up during the morning of trading on Monday and closed up one cent at closing.

To view our StockGuru Spotlight on New Leaf Brands Inc. (OTCBB: NLEF), please visit:

http://www.stockguru.com 

What is the StockGuru Spotlight? 

The StockGuru Spotlight features stocks that we expect some action in. Generally speaking we expect a strong showing in the market based on the market, our knowledge of the stock and the buzz in the markets. Many times these will be stocks that have big news out recently, there is fresh interest in getting the word out on these stocks or we hear a buzz in our day to day contacts on these stocks. If we think it is going to move or see action, we put it in the StockGuru Spotlight.  If we are compensated for a stock in the Spotlight, it will be clearly disclosed within this Spotlight Announcement. 

If you think a company should be featued in the StockGuru Spotlight, please let us know. If you are a key person for a publicly traded company, we can consider your company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact our Publisher John Pentony at the john@stockguru.com.  You may also telephone John Pentony at (469) 252-3031. 

Stockguru.com (”SG”) provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.Stockguru.com or mentioned herein. 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. Pentony Enterprises LLC is occassionally compensated for coverage.  When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present, plus we also disclose any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. 
 

John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: john@stockguru.com

On Monday, the company put out news announcing that the Company has received interest from major Carbon Black manufacturers who have recognized the significant competitive advantage that the QES System has for producing Carbon Black. Carbon Black is an engineered material that improves the strength, durability and overall performance of a range of products including tires and other mechanical rubber goods, as well as inks, paints, plastics and coatings, and is one of the key components of manufactured tires, representing approximately 25% of the weight of automotive tires.

Shares for Quadra Projects Inc. (OTCBB: QPRJ) were down during the late morning of trading on Monday and closed slightly down at closing.
 

To view our StockGuru Spotlight on Quadra Projects Inc. (OTCBB: QPRJ), please visit:

http://www.stockguru.com 

What is the StockGuru Spotlight? 

The StockGuru Spotlight features stocks that we expect some action in. Generally speaking we expect a strong showing in the market based on the market, our knowledge of the stock and the buzz in the markets. Many times these will be stocks that have big news out recently, there is fresh interest in getting the word out on these stocks or we hear a buzz in our day to day contacts on these stocks. If we think it is going to move or see action, we put it in the StockGuru Spotlight.  If we are compensated for a stock in the Spotlight, it will be clearly disclosed within this Spotlight Announcement. 

If you think a company should be featued in the StockGuru Spotlight, please let us know. If you are a key person for a publicly traded company, we can consider your company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact our Publisher John Pentony at the john@stockguru.com.  You may also telephone John Pentony at (469) 252-3031. 

Stockguru.com (”SG”) provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.Stockguru.com or mentioned herein. 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. Pentony Enterprises LLC is occassionally compensated for coverage.  When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present, plus we also disclose any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. 
 

John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: john@stockguru.com

On Monday, the company put out news announcing its CYIPRO’s features to support Telework and Business Continuity to all federal agencies. “Not all jobs can be worked from anywhere – but the jobs that can be accomplished from anywhere should be aggressively doing so. Moreover, take a job that can be teleworked and move that job to a lower salary based district or U.S. State as we internally are doing today. Savings will be immediately recognized and a flood of other events will follow – we think it’s going to be the next technological change agent that creates a positive effect for our current economy,” stated CEO Timothy Carnahan.

Shares for CYIOS Corp. (OTCBB: CYIO) were up during the afternoon of trading on Monday and closed slightly up at closing.

To view our StockGuru Spotlight on CYIOS Corp. (OTCBB: CYIO), please visit:

http://www.stockguru.com 

What is the StockGuru Spotlight? 

The StockGuru Spotlight features stocks that we expect some action in. Generally speaking we expect a strong showing in the market based on the market, our knowledge of the stock and the buzz in the markets. Many times these will be stocks that have big news out recently, there is fresh interest in getting the word out on these stocks or we hear a buzz in our day to day contacts on these stocks. If we think it is going to move or see action, we put it in the StockGuru Spotlight.  If we are compensated for a stock in the Spotlight, it will be clearly disclosed within this Spotlight Announcement. 

If you think a company should be featued in the StockGuru Spotlight, please let us know. If you are a key person for a publicly traded company, we can consider your company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact our Publisher John Pentony at the john@stockguru.com.  You may also telephone John Pentony at (469) 252-3031. 

Stockguru.com (”SG”) provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.Stockguru.com or mentioned herein. 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. Pentony Enterprises LLC is occassionally compensated for coverage.  When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present, plus we also disclose any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. 
 

John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: john@stockguru.com

On Monday, the company put out news announcing that The Company is making its voice over Internet Protocol (VoIP) softphones available for free to all provincial businesses, academic institutions and government agencies in the area. To help British Columbia enterprises and their workforces maximize productivity and avoid gridlock during the upcoming 2010 Olympic Winter Games.  CounterPath will distribute softphones through Feb. 28 and validate accounts for 60 days upon activation.  CounterPath’s VoIP platform gives CIOs and IT managers a fast, convenient option for supporting telecommuting, which 70 percent of British Columbia enterprises plan to expand or begin offering in time for the 2010 Games, according to a BC Human Resources Management Association survey. Although the 2010 Games span a little over two weeks – Feb. 12-28 – the survey found that the impact on employee commutes will last six to 10 weeks. 

Shares for CounterPath Corp. (OTCBB: CPAH) were up during the afternoon of trading on Monday and closed up five cents at closing.

To view our StockGuru Spotlight on CounterPath Corp. (OTCBB: CPAH), please visit:

http://www.stockguru.com 

What is the StockGuru Spotlight? 

The StockGuru Spotlight features stocks that we expect some action in. Generally speaking we expect a strong showing in the market based on the market, our knowledge of the stock and the buzz in the markets. Many times these will be stocks that have big news out recently, there is fresh interest in getting the word out on these stocks or we hear a buzz in our day to day contacts on these stocks. If we think it is going to move or see action, we put it in the StockGuru Spotlight.  If we are compensated for a stock in the Spotlight, it will be clearly disclosed within this Spotlight Announcement. 

If you think a company should be featued in the StockGuru Spotlight, please let us know. If you are a key person for a publicly traded company, we can consider your company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact our Publisher John Pentony at the john@stockguru.com.  You may also telephone John Pentony at (469) 252-3031. 

Stockguru.com (”SG”) provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.Stockguru.com or mentioned herein. 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. Pentony Enterprises LLC is occassionally compensated for coverage.  When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present, plus we also disclose any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. 
 

John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: john@stockguru.com

On Monday, the company put out news announcing that it has completed a preliminary study with a leading pharmaceutical company that validates the use of its licensed COLD-PCR technology to detect colorectal tumor-associated KRAS mutations that determine efficacy of recently developed therapies. These were detected in plasma samples in which the mutation levels were too low for detection by standard DNA analysis methodologies such as Sanger sequencing.

Shares for Transgenomic Inc. (OTCBB: TBIO) were up during the late afternoon of trading on Monday and closed up two cents at closing.

To view our StockGuru Spotlight on Transgenomic Inc. (OTCBB: TBIO), please visit:

http://www.stockguru.com 

What is the StockGuru Spotlight? 

The StockGuru Spotlight features stocks that we expect some action in. Generally speaking we expect a strong showing in the market based on the market, our knowledge of the stock and the buzz in the markets. Many times these will be stocks that have big news out recently, there is fresh interest in getting the word out on these stocks or we hear a buzz in our day to day contacts on these stocks. If we think it is going to move or see action, we put it in the StockGuru Spotlight.  If we are compensated for a stock in the Spotlight, it will be clearly disclosed within this Spotlight Announcement. 

If you think a company should be featued in the StockGuru Spotlight, please let us know. If you are a key person for a publicly traded company, we can consider your company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact our Publisher John Pentony at the john@stockguru.com.  You may also telephone John Pentony at (469) 252-3031. 

Stockguru.com (”SG”) provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.Stockguru.com or mentioned herein. 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. Pentony Enterprises LLC is occassionally compensated for coverage.  When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present, plus we also disclose any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. 
 

John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: john@stockguru.com

Medizone International, Inc.(OTCBB: MZEI)

VIEW PROFILE – VIEW MEDIZONE WEB SITE

Dear Member,

The following Chairman’s Message was just released by Edwin Marshall, the CEO and Chairman of the Board of Medizone International:

John Pentony
Publisher, StockGuru

Chairman’s Message

Shareholder Update, February 8, 2010

Let me start by wishing everyone an excellent 2010.  Medizone reached milestones during 2009 relative to the AsepticSure™ development program that sets the pulse not only for a very successful 2010, but I believe has laid the foundation for achieving full commercialization in the area of hospital sterilization and critical infrastructure clean up in addition to the exceedingly strong likelihood of contributing greatly in the area of bio-terrorism counter measures. These are two distinct avenues of revenue production, both with an increasingly high likelihood of commercial success.

I would like to acknowledge the tremendous level of leadership skill that has been demonstrated by Dr. Michael Shannon, one of Medizone’s Board Members and our Director of Medical Affairs. Michael has been instrumental in the building of a research and development team that may be un-paralleled for a company of Medizone’s size. The accomplishments this group of esteemed men has achieved is remarkable.  To repeatedly and predictably be able to achieve 6 log (99.9999%) sterilization standards of bactericidal kill across the full spectrum of bacteria we have worked with in open space settings is unprecedented.  It is amazing to me that our development team has reached these previously unachievable levels of scientific success in only one year.  A year ago initial conversations were in the works with those who are now our key people about the possibility of developing equipment to help rid hospitals of HAIs, and the science we thought it would take to reach that goal.  We had no equipment, nor a laboratory, but together we did bring a wealth of experience, knowledge, ideas and a team of incredibly talented bright people that were destined to find a synergy, a magic, in working together on a unique project. Today, we have three highly successful laboratory trials behind us and a full scale hospital mock up trial in progress, which has already demonstrated our equipment will deliver as promised in the field, and two new patent applications filed for commercial protection.  What a difference one year has made!  Remarkable!

In recapping our work in 2009 that set the agenda for moving forward from where we are today, let me start by broadly reviewing the steps that have brought us to this present stage.  In the first round of trials, working just with ozone as the primary agent, we achieved in the area of 3 log (99.9%) to 4 log (99.99%) of bactericidal reductions on average.  For the second round of trials our “formula” was tweaked a little bit, and the results improved by a log on average, putting us solidly in the 4 log to 5 log range. With an impressive amount of data logging achieved, and following a thorough search of the patent literature by two patent firms, our first patent application was filed for AsepticSure™ July 6, 2009 titled “Healthcare Facility Disinfecting System” US application 61/223,219. That filing made three distinct and unique claims based not only on inventive engineering design and protocols, but backed up with solid scientific evidence that was demonstrated to be repeatable. This patent protects the Company’s basic disinfectant procedure and protocol, involving the use of ozone-containing atmosphere, and the apparatus used for implementing it.

For the third round of trials recently completed, an additional technology was integrated that catapulted AsepticSure™ to the accepted sterilization standard of 6 logs or greater (99.9999% bactericidal kill.)  This result is phenomenal in that Medizone is the only company in the world known to have reached this standard, and it has done so using a product that is portable, affordable and is now proving capable of full room sterilization with a turn around time of 2 hours or less for re-use, while not damaging electronics and other built in infrastructure within the room.

The actual measured numbers of bactericidal reduction from the completed third round of laboratory trials when compared to the larger samples were >6.5 log for C difficile, >7 log for MRSA, 7 log for E-coli, 6.6 Log for VRE, 7 log for Pseudomonas aeruginous and > 7 log for Bacillus subtilis.  Given this unprecedented scientific data and the protocols compiled as part of the patent applications, in combination with the uniqueness of the invention itself, gives Medizone every confidence that our patent protection will stand firm and strong and protect the commercial rights of shareholders well into the future as Medizone transitions to a revenue producing company.

A second patent filing for AsepticSure™ was announced on January 20, 2010 titled “Disinfecting Process and Apparatus” US application 61/295,851. This protects improvements in the Company’s basic procedure and protocol achieved by combining it with another procedure, resulting in a significant increase in disinfecting capabilities demonstrated during the third round of laboratory trials against a wide variety of bacteria and on a range of different surfaces commonly found in healthcare and other essential facilities.  Both patent applications currently afford international protection for this technology, and can be expanded into full international patent applications, in countries of the Company’s choice, in the months ahead.

On February 4th 2010 Medizone announced a successful progression to full room scale testing, achieving total eradication (>6 logs) with all bacteria tested to date (MRSA, VRE and E coli) on every single run.  Additional testing now underway with the remaining causative agents of HAIs, are expected to replicate the results achieved in our small laboratory test unit with the remaining bacteria, just as these early mock trial results have already proven.  It was stated in the February 4 th press release, “It now seems certain that AsepticSure™ will deliver as promised.” It is a simple statement, but absolutely true!

2010 is clearly starting out as great year for Medizone International. I believe it will prove to be a year of dramatic transition, accomplishment and reward.  The goal of becoming a significant revenue producing company is progressing toward reality with an historic scientific product that we believe is strongly protected intellectually. When the mock trials currently underway are completed, we expect to then be positioned to move into hospital beta testing at sites in both the United States and Canada.  The final step is then expected to be sales and partnering with major corporate partners already fully imbedded in the hospital sector for additional manufacturing, sales and service support.  As results are produced in the field in the form of cleaner hospitals and a reduced incident of HAIs, it is assured that product demand will be strong. The potential for Medizone International to now develop into a solid, revenue producing growth company for many years to come is significant.  I believe the year 2010 will prove to be historic in our company’s history.

To be able to greatly reduce human suffering, save thousands if not tens of thousands of lives and be able to significantly reduce hospital operating costs all in one broad stroke called AsepticSure™, will truly prove to be a significant achievement in the history of science and medicine.  I believe Medizone International is now firmly on the threshold of that achievement.  Stand by, I promise you there will be more news to come in the months ahead!

Yours truly,

Edwin G. Marshall

Chairman of the Board

Chief Executive Officer

This Chairman’s message contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.

.

Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 450,000 144 restricted common shars by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

]]> http://www.stockguru.com/2010/02/medizone-international-inc-otcbb-mzei-issued-chairmans-message-today-great-update-on-mzei/feed/ 0 http://www.stockguru.com/2010/02/halo-companies-inc-gpax-otcbb-expanding-services-growing-client-base/#utm_source=feed&utm_medium=feed&utm_campaign=feed http://www.stockguru.com/2010/02/halo-companies-inc-gpax-otcbb-expanding-services-growing-client-base/#comments Mon, 08 Feb 2010 14:50:01 +0000 StockGuru http://www.stockguru.com/?p=8289

Halo Companies, Inc.

Halo has twelve companies under one roof and nine of them have distinct core competencies and able to operate as stand-alone businesses.  We witnessed with the recent press release ‘how Halo does it.’  This recent expansion into identity theft is precisely how Halo has developed nine distinct entities which enhance growth for the over-all business.

As Halo turns its growth to business to business this will be a fundamental product and enticement for other businesses.  Halo Benefits, Inc., the B2B vehicle through which Halo provides benefits to employers, associations, and resellers, will now offer HaloSafe ID as an a-la-carte product within their bundle of services.

HaloSafe ID, scheduled to roll-out before the second quarter, stays true to Halo’s product profile by offering the most complete identity theft services available on the market.  While typical competitor products offer restoration and limited monitoring only, HaloSafe ID includes insurance (up to $25,000), extensive monitoring, document preparation, financial coaching, legal consulting, and a stolen purse/loss wallet.

This just one more step in Halo’s growth with added services.

One Allen Center
Suite 500
700 Central Expressway South
Allen, TX 75013
Phone: 214-644-0065

About Halo Companies, Inc.

Halo Companies, Inc. is a nationwide holding company based in Allen, TX with ten subsidiaries that operate primarily in the consumer financial services industry including debt, mortgage, real estate, credit, loan modification, and insurance. Halo has been recently recognized by Inc. Magazine, Comerica Bank’s Collin 60, and the SMU Cox School of Business Dallas 100. For more information about Halo Companies, Inc., visit www.myhalogroup.com.

Cautionary Language Concerning Forward-Looking Statements:

Information set forth in this profile contains financial estimates and other forward-looking statements that are subject to risks and uncertainties, and actual results might differ materially. A discussion of factors that may affect future results is contained in Halo Companies Inc.’s filings with the Securities and Exchange Commission. Halo Companies, Inc. disclaims any obligation to update and revise statements contained in this profile based on new information or otherwise.

Disclosure

Pentony Enterprises LLC is STOCKGURU.COM. 10604 Robincreek Lane; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was paid thirteen thousand dollars by the company for profile coverage. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. We will not be buying or selling shares of Halo Companies, Inc. (OTCBB: GPAX) during the promotional period.